LifeCell

United States Founded: 1986 • Age: 40 yrs Acquired By Allergan
Tissue repair products for regenerative medicine are developed and marketed.

About LifeCell

LifeCell is a Healthcare company based in United States founded in 1986, and was acquired by Allergan in December 2016. Tissue repair products for regenerative medicine are developed and marketed. LifeCell has raised $14 million across 5 funding rounds from investors including U.S Army, Allergan and U.S. Department of Defense. Its focus areas include Life Sciences, Dermatology, Medical Devices and Therapeutic Devices. Its legal entity is LIFECELL CORP. Its competitors include RevBio, Dimension Inx and LambdaVision; 3 of its 3 listed competitors have raised funding.

Company details

LifeCell was founded in 1986 in the United States and operates as a subsidiary of Kinetic Concepts. Tissue repair products are developed and marketed for reconstructive, orthopedic, and urogynecological surgeries. Key offerings include Strattice and AlloDerm for plastic and general procedures, Repliform for urogynecology, GraftJacket for orthopedics, and AlloCraft DBM for bone grafting. Distribution occurs through partners in the United States and internationally. An investment by Turkcell preceded the acquisition.

  • Headquarters United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website lifecell.com
  • Social LinkedIn
  • Acquired by Allergan (Dec 2016)
  • Legal Name Lifecell Corp
Key Metrics
  • Total Equity Funding
    $14M (USD)

    in 5 rounds

  • Latest Funding Round
    $1.85M (USD), Grant

    Jan 2008

  • Investors
    U.S Army

    & 3 more

  • Acquired by
    Allergan

    (Dec 2016)

Funding Insights of LifeCell

LifeCell has successfully raised a total of $14M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $1.85 million completed in January 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $14M
  • Total Rounds 5
  • Last Round Grant β€” $1.85M
  • First Round $2.1M

    (Oct 2001)

  • Investors Count 3

All 5 funding rounds of LifeCell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2008$1.85MGrant––
Jun 2004Series A––
–
Aug 2003$14MSeries A––
–
Feb 2002$824,000Grant––
Oct 2001$2.1MGrant––
Valuation history

4 investors in total: 4 institutional.

Investors in LifeCell

LifeCell has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include U.S Army, Allergan and U.S. Department of Defense.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Land-based military forces are organized and deployed for national defense.
1775army.mil
Military forces are provided by the U.S. Department of Defense for national security.
defense.govWashington, D.C., United States
Administers health care and support for military personnel and operations.
health.milFalls Church, United States
A portfolio of generic medicines is developed and manufactured.
1948allergan.comMadison, United States
Premium access

Investor details for LifeCell

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of LifeCell

4 dated milestones of LifeCell across 30 years, from founding to its latest funding, stage changes and deals.

  1. Founded LifeCell is founded.
  2. Funding First funding round of $2.1M.
  3. Funding Latest funding round, Grant, of $1.8M.
  4. Exit Acquired by Allergan.

Competitors of LifeCell

LifeCell has 3 listed competitors in our database, 3 of them funded. They include RevBio, Dimension Inx and LambdaVision.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
revbio.com2014Lowell, United States$24.42M
Synthetic adhesives for bone and dental repair are developed.
dimensioninx.com2017Chicago, United States$15.42M
3D biomaterials are provided for regenerative medicine applications.
lambdavision.com2009Farmington, United States$650,0007
Protein-based retinal prosthesis for degenerative eye diseases is provided.
Premium access

Detailed competitors of LifeCell

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of LifeCell

Websites that share an audience with LifeCell (lifecell.com).

Similar websites

Websites whose visitors overlap most with LifeCell. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lexionmedical.com
100%
#6,386,828View details
lifecellcream.com
95%
View details
leechesusa.com
leechesusa.com
91%
#6,100,390–
lifecore.com
86%
6.8K#2,972,881View details
acelity.com
84%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 9 similar websites and full traffic analytics for LifeCell

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 9 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Dermatology

3 companies that operate in the same segment as LifeCell (Dermatology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lifecell

Premium access

Complete news archive for LifeCell

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about LifeCell

LifeCell was founded in 1986 and raised its 1st funding round 15 years after it was founded.

LifeCell is headquartered in United States.

LifeCell is a funded company, having raised a total of $14M across 5 funding rounds to date. The company's 1st funding round was a Grant of $2.1M, raised on Oct 2001.

LifeCell was founded in 1986 in the United States and operates as a subsidiary of Kinetic Concepts. Tissue repair products are developed and marketed for reconstructive, orthopedic, and urogynecological surgeries. Key offerings include Strattice and AlloDerm for plastic and general procedures, Repliform for urogynecology, GraftJacket for orthopedics, and AlloCraft DBM for bone grafting. Distribution occurs through partners in the United States and internationally. An investment by Turkcell preceded the acquisition.

LifeCell's top competitors include RevBio, Dimension Inx and LambdaVision.

LifeCell has 4 investors. Key investors include U.S Army, Allergan, U.S. Department of Defense, and Military Health.

LifeCell operates through Lifecell Corp.

Yes. LifeCell was acquired by Allergan in December 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available